Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)-Reference-Cited by-同舟云学术

Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)

Published:2020-11 Issue: Volume:195 Page:125-127
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Zanon Ezio,Pasca Samantha,Spiezia Luca,Poletto Francesco,Gherardi Simone,Simioni Paolo

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. Unsuspected acquired haemophilia in a patient with myocardial infarction;Foley;J. R. Soc. Med.,2004

2. Management of a myocardial infarction in a patient with classical acquired haemophilia patient in partial remission;Routledge;Haemophilia.,2015

3. EACH2 registry contributors. Management of bleeding in acquired hemophilia a: results from the European acquired Haemophilia (EACH2) registry;Baudo;Blood,2012

4. Acquired hemophilia a: updated review of evidence and treatment guidance;Kruse-Jarres;Am. J. Hematol.,2017

5. Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia a;Kruse-Jarres;Haemophilia,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study;Haemophilia;2024-02-05

2. Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review;Journal of Clinical Medicine;2023-07-10

3. Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa;Diagnostics;2022-08-18

4. Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study;Haemophilia;2021-12-08

5. Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 2021;Research and Practice in Thrombosis and Haemostasis;2021-11-21